Partnership addresses biopharmaceutical industry’s urgent need for improved in-process and QC testing tools for these rapidly evolving application fields BOULDER, Colo., June 5, 2024 (Newswire.com) – InDevR, Inc.,…
Read more InDevR and Sino Biological Team Up to Deliver Multiplexed Analytical Solutions for mRNA Vaccine and Cell & Gene TherapyYou’ve probably heard of RNA recently because of the new type of RNA vaccines that have saved millions of lives around the world from COVID-19. But RNA, or…
Read more WTF Fun Fact 13715 – Types of RNAUpdated Oct. 17, 2023 2:47 am ET Lonza Group warned that its profitability will take a hit next year from losing revenue from an agreement with Moderna and…
Read more Lonza Warns on 2024 Profitability Hit From Lost Moderna RevenueThis copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/stock-market-movers-8c0c7b23 Updated Sept. 19, 2023…
Read more NIO, Moderna, Block, U.S. Steel, and More Stock Market MoversIt may be time to get your COVID-19 vaccine again. There’s a new booster that’s coming out to guard against the virus. The Centers for Disease Control and…
Read more 5 things to know about the new COVID-19 vaccineThe Centers for Disease Control and Prevention on Tuesday recommended updated COVID-19 vaccines for people 6 months of age and older. Director Mandy Cohen late Tuesday backed the…
Read more CDC recommends updated COVID shots for people 6 months of age and olderModerna Inc.’s stock MRNA, -3.26% rallied 5.5% in premarket trade Thursday, after the COVID vaccine market posted a narrower-than-expected second-quarter loss and revenue that was far below last…
Read more Moderna’s stock jumps 5% premarket after narrower-than-expected loss and revenue beatModerna Inc. said Tuesday it’s working to develop its first bacterial vaccine to protect against Lyme disease, the tick-borne illness that causes a range of painful symptoms, including…
Read more Moderna is developing a Lyme disease vaccine in a first for the companyModerna Inc. MRNA, +1.19% outlined its clinical goals for its mRNA platform on Tuesday to mark its 4th Vaccine Day, including a new development candidate against Lyme disease…
Read more Moderna is developing a vaccine candidate against Lyme disease that would be its first bacterial vaccineA Food and Drug Administration advisory panel voted unanimously Thursday for Americans to get a once-a-year booster against COVID-19, with the strain to be decided midyear for a…
Read more FDA panel backs plan for annual COVID-19 booster, as new omicron subvariant continues to dominate in new casesChina has accused “some Western media” of bias and political manipulation in covering China’s abrupt dropping of COVID restrictions, which has led to a wave of new cases…
Read more China slams Western media for criticism of zero-COVID, as U.S. cases continue to declineThe World Health Organization has called on China to release more information about its current wave of COVID infections after China said nearly 60,000 people have succumbed to…
Read more WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulatingThe XBB.1.5 omicron subvariant that has been dominant in the Northeast for several weeks is now officially dominant across the U.S., according to an update from the Centers…
Read more New COVID subvariant is now dominant across the U.S., accounting for 43% of all new cases in latest week, CDC saysChina on Tuesday suspended visas for South Koreans to enter the country for tourism or business in apparent retaliation for South Korea’s COVID-19 testing requirements for Chinese travelers, the…
Read more China takes first steps to punish countries that imposed testing mandates for Chinese travelersA flurry of announcements relating to COVID vaccines dominated headlines on the pandemic on Monday, with Moderna telling investors it expects to generate some $5 billion in sales…
Read more Moderna, CureVac and Ocugen offer updates on COVID vaccines, while China cracks down on critics of government’s pandemic responseModerna Inc. Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines,…
Read more MRNA Stock Price | Moderna Inc. Stock Quote (U.S.: Nasdaq) | MarketWatchThe Food and Drug Administration on Thursday authorized the bivalent COVID-19 boosters made by Moderna Inc. MRNA, +3.18% and BioNTech SE BNTX, +5.64% /Pfizer Inc. PFE, +3.07% for…
Read more FDA to allow bivalent COVID boosters for some infants and young childrenThe head of the International Monetary Fund on Tuesday joined the chorus of people urging China to adopt a more targeted approach to the coronavirus pandemic as the…
Read more IMF head joins chorus calling on China to adapt COVID strategy as officials pledge to boost vaccinations among elderlyWidespread protests across China over the government’s zero-COVID policy dominated pandemic headlines Monday, with Anthony Fauci, President Joe Biden’s chief medical adviser, weighing in with the view that…
Read more China’s zero-COVID strategy makes no sense and its homegrown vaccines are not ‘particularly effective,’ says FauciAs we head into the third winter of the pandemic, only about 13% of American adults — less than 11% of Americans overall — have received the bivalent…
Read more Confused about COVID boosters? Here’s what the science and the experts say about the new generation of shots.
